| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e34bb79b7326bc5afb454a1dcd48670c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
1996-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bfd76ef83527980a6b991495fb1a9b9 |
| publicationDate |
1998-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5712259-A |
| titleOfInvention |
NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome |
| abstract |
A method for treating Chronic Fatigue Syndrome or alleviating symptoms thereof wherein the reduced form of nicotinamide adenine dinucleotide (NADH) or the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) or physiologically compatible salts or derivatives of NADH and/or NADPH are administered to a person suffering from the syndrome or its symptoms. Patients so treated exhibit greatly improved physical strength and performance over time, and their symptoms including fatigue, muscle pain and weakness, and headaches are greatly alleviated. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021180916-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102012104451-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004000043-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012129803-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11203769-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022133497-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9890397-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9953921-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10947566-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6248552-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013045538-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021180915-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2786774-R1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004126751-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004000043-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2574339-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104306390-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004057961-A1 |
| priorityDate |
1996-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |